Subtype
Uterine Neoplasm
CI-CAN-00004208Explore in graph →
Non-malignant925 active trials7 approved drugs44 evidence items
Loading cancer entity…
Subtype
CI-CAN-00004208Explore in graph →
Clinical trials
3,823 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02896413 | The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients With Uterine Cancer Undergoing Radical Resection | completed | N/A | 100 | Yonsei UniversityOTHER | 1 | May 4, 2021 | clinicaltrials |
| NCT02354534 | Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3) | completed | Phase 1 | 30 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Apr 28, 2021 |
| clinicaltrials |
| NCT02269293 | Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers | completed | Phase 1 | 23 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 23, 2021 | clinicaltrials |
| NCT01065662 | AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies | completed | Phase 1 | 11 | Susana M. Campos, MDOTHER | 1 | Apr 21, 2021 | clinicaltrials |
| NCT02394652 | The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial | completed | Phase 2 | 16 | University Health Network, TorontoOTHER | 1 | Apr 21, 2021 | clinicaltrials |
| NCT02367625 | Performance, Safety, and Efficacy of a New Cyrotherapy Device for Cervical Dysplasia | completed | N/A | 40 | JhpiegoOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT03112668 | Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners | completed | N/A | 14 | Rutgers, The State University of New JerseyOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT03813940 | Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) | completed | Phase 1 | 24 | Xiamen UniversityOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT03935204 | Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) | completed | Phase 2 | 627 | Xiamen UniversityOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT04809727 | Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy(HSTH) | completed | N/A | 88 | Tanta UniversityOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT04832906 | UA Versus UAE in Treatment of Fibroids | completed | Phase 4 | 70 | Ain Shams Maternity HospitalOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT04830332 | Correlation of Peritoneal Fluid CA-125 Levels With Postoperative Tumor Histology | completed | N/A | 50 | Erdemli State HospitalOTHER | 1 | Apr 5, 2021 | clinicaltrials |
| NCT01654458 | A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer | completed | N/A | 398 | Women's College HospitalOTHER | 2 | Mar 18, 2021 | clinicaltrials |
| NCT03908996 | the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer | completed | N/A | 25 | Sanford HealthOTHER | 1 | Mar 18, 2021 | clinicaltrials |
| NCT03070951 | Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids(PRIMROSE 2) | completed | Phase 3 | 511 | ObsEva SAINDUSTRY | 9 | Mar 5, 2021 | clinicaltrials |
| NCT03824613 | Urinary miRNA in Endometrial Cancer Study | completed | — | 164 | Royal Cornwall Hospitals TrustOTHER | 1 | Mar 1, 2021 | clinicaltrials |
| NCT03021720 | Satisfaction of Patients With Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial(SPARQLE) | completed | N/A | 40 | Mount Sinai Hospital, CanadaOTHER | 1 | Feb 25, 2021 | clinicaltrials |
| NCT01569672 | Ohio Patient Navigator Research Program(OPNRP) | completed | N/A | 941 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Feb 23, 2021 | clinicaltrials |
| NCT02172911 | A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer | completed | Phase 1 / Phase 2 | 10 | Inovio PharmaceuticalsINDUSTRY | 1 | Feb 21, 2021 | clinicaltrials |
| NCT03502798 | Coherence Imaging of the Cervical Epithelium With Scanning a/LCI | completed | N/A | 45 | Duke UniversityOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT03444987 | The Role of Fibroblast Activation in Uterine Fibroid | completed | — | 35 | Assiut UniversityOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT01627288 | Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial)(IDEAL) | completed | N/A | 12 | Duke UniversityOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT02267876 | Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens | completed | — | 6,730 | Becton, Dickinson and CompanyINDUSTRY | 2 | Feb 8, 2021 | clinicaltrials |
| NCT01365156 | Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix | completed | Phase 3 | 28 | M.D. Anderson Cancer CenterOTHER | 2 | Feb 3, 2021 | clinicaltrials |
| NCT02682693 | Denosumab as an add-on Neoadjuvant Treatment (GeparX)(GeparX) | completed | Phase 2 | 780 | GBG Forschungs GmbHOTHER | 1 | Feb 2, 2021 | clinicaltrials |
| NCT02725489 | Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers | completed | Phase 2 | 13 | Mary Crowley Medical Research CenterOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT02594826 | Cervical Cancer Screening Intervention Among Korean American Women | completed | N/A | 744 | Fox Chase Cancer CenterOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT01840124 | Uterine Leiomyoma Treatment With Radiofrequency Ablation(ULTRA) | completed | N/A | 26 | University of California, San FranciscoOTHER | 1 | Jan 25, 2021 | clinicaltrials |
| NCT04351139 | Impact of the COVID-19 Pandemic in Gynecological Oncology(COVID-GYN) | completed | — | 205 | Hospices Civils de LyonOTHER | 1 | Jan 19, 2021 | clinicaltrials |
| NCT03697226 | Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection. | completed | Phase 1 | 8 | Antiva BiosciencesINDUSTRY | 1 | Jan 13, 2021 | clinicaltrials |
| NCT01851772 | Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer | completed | N/A | 3 | Xoft, Inc.INDUSTRY | 1 | Jan 12, 2021 | clinicaltrials |
| NCT01101750 | Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls? | completed | Phase 4 | 25 | Medstar Health Research InstituteOTHER | 1 | Jan 5, 2021 | clinicaltrials |
| NCT03137563 | Acceptability of HPV-self Sampling | completed | — | 356 | University Hospital, MontpellierOTHER | 1 | Dec 31, 2020 | clinicaltrials |
| NCT01338831 | Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer | completed | Phase 1 | 73 | Novartis PharmaceuticalsINDUSTRY | 4 | Dec 17, 2020 | clinicaltrials |
| NCT02934724 | Impact of HPV Vaccine On The Prevalence Of HPV In Norway | completed | — | 315 | Oslo University HospitalOTHER | 1 | Dec 14, 2020 | clinicaltrials |
| NCT02506816 | Preoperative Olaparib Endometrial Carcinoma Study (POLEN)(Polen) | completed | — | 36 | MedSIROTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT02093598 | POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus(POEM) | completed | Phase 2 | 10 | MedSIROTHER | 1 | Nov 27, 2020 | clinicaltrials |
| NCT00804466 | Human Papillomavirus Epidemiology in Nigeria | completed | N/A | 1,466 | National Cancer Institute (NCI)NIH | 1 | Nov 25, 2020 | clinicaltrials |
| NCT03241914 | Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer | completed | Phase 2 / Phase 3 | 64 | Fudan UniversityOTHER | 1 | Nov 20, 2020 | clinicaltrials |
| NCT02260752 | Patient Centered Results for Uterine Fibroids(COMPARE-UF) | completed | — | 3,094 | Duke UniversityOTHER | 1 | Nov 18, 2020 | clinicaltrials |
| NCT00879840 | Assessment of Screening Modalities for Gynecologic Cancers | completed | — | 118 | National Cancer Institute (NCI)NIH | 1 | Nov 17, 2020 | clinicaltrials |
| NCT01793545 | Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples | completed | — | 1,932 | National Cancer Institute (NCI)NIH | 1 | Nov 17, 2020 | clinicaltrials |
| NCT00340600 | Continuation of Follow-up of DES-Exposed Cohorts | completed | — | 10,805 | National Cancer Institute (NCI)NIH | 1 | Nov 16, 2020 | clinicaltrials |
| NCT04626895 | Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers | completed | N/A | 15 | Medstar Health Research InstituteOTHER | 1 | Nov 13, 2020 | clinicaltrials |
| NCT03744507 | Bone Mineral Density in Women With Uterine Fibroids or Endometriosis | completed | — | 660 | Myovant Sciences GmbHINDUSTRY | 7 | Nov 10, 2020 | clinicaltrials |
| NCT04617236 | Cultivando la Salud: A Breast and Cervical Cancer Screening Promotion Program for Low-Income Puerto Rican Women(CLS) | completed | N/A | 444 | University of Puerto RicoOTHER | 1 | Nov 5, 2020 | clinicaltrials |
| NCT04603599 | Relationship of Endometrial Cancer and Serum Soluble L1CAM Level | completed | — | 146 | Kocaeli UniversityOTHER | 1 | Nov 2, 2020 | clinicaltrials |
| NCT00444054 | The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer(RECHARGE) | completed | N/A | 10 | Albert Einstein College of MedicineOTHER | 1 | Oct 30, 2020 | clinicaltrials |
| NCT03538028 | A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies | completed | Phase 1 | 22 | Incyte Biosciences International SàrlINDUSTRY | 1 | Oct 30, 2020 | clinicaltrials |
Data updated 24 days agoSource updated May 4, 2021source: clinicaltrials